The information provided in this report

The information provided in this report
reflects transactions of:
• thirty-nine formulations commonly used
for adult HIV treatment 12,13
• thirty-three formulations for paediatric
treatment recommended by WHO for the
first and second-line regimens 10,14
• twenty HIV serology tests (fifteen
rapid, six ELISA, and four confirmatory)
purchased by low-income, lower middleincome
and upper-middle-income
countries
The GPRM also contains data for less
frequently used ARV formulations, medicine
for opportunistic infections, medicines for
malaria and tuberculosis treatment, and
other health commodities related to the
treatment of HIV, TB and malaria. However,
this summary report does not include those
data due to limited transaction volumes for
the relevant commodities.